Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page
- Check6 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedSite-wide Revision: v3.4.2 was posted and the prior v3.4.1 funding/operating status notice was removed, with no changes to the study content on the NCT02926898 page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA new site-wide notice about a lapse in government funding was added, directing users to cc.nih.gov and opm.gov for updates. The revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page received minor editorial/UI updates: a glossary toggle was added, and several labeling/version fields were added (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while previous labels with different capitalization were removed (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a minor revision update: Revision v3.3.4 was added and v3.3.3 was removed, with no impact on study content, eligibility criteria, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's Locations section has been expanded and reorganized to include new site regions: California, Colorado, Illinois, Michigan, Minnesota, British Columbia, Quebec, and Scotland. The page revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.8%

Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.